title: Endoprostatic stents for management of benign prostatic hyperplasia.
abstract: Endoprostatic stents have been developed for relieving bladder outlet obstruction secondary to benign hyperplasia of the prostate. The stents are designed either for permanent or for temporary placement. The short-term temporary stents of various biostable and biodegradable polymers are needed after minimally invasive therapy of prostate with heat. The temporary stents are a management option, whereas the permanent stents are a treatment option. Permanent stents offer immediate relief and their sustained results for 4-7 years make them ideally suited for medically compromised patients.
authors.affiliation: Albert Einstein College of Medicine, Long Island Jewish Medical Center, Department of Urology, New York, NY 11042, USA.
authors.forename: R
authors.initials: R
authors.lastname: Kapoor
authors.forename: E N
authors.initials: EN
authors.lastname: Liatsikos
authors.forename: G
authors.initials: G
authors.lastname: Badlani
mesh_terms: D001672:Biocompatible Materials; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000150:complications*; D015607:Stents; D014524:Urethral Obstruction / Q000628:therapy*
chemical_list: D001672:Biocompatible Materials